Gastrointestinal Stromal Tumors News and Research

RSS
VARI researchers find ways to reverse resistance to sunitinib: Patients with ccRCC show positive response

VARI researchers find ways to reverse resistance to sunitinib: Patients with ccRCC show positive response

Synta Pharmaceuticals initiates STA-9090 Phase 2 clinical trial for GIST

Synta Pharmaceuticals initiates STA-9090 Phase 2 clinical trial for GIST

Data on Synta Pharmaceuticals' STA-9090 synthetic inhibitor of Hsp90 presented

Data on Synta Pharmaceuticals' STA-9090 synthetic inhibitor of Hsp90 presented

Marker genes help determine the effectiveness of targeted molecular drug regimen for treating GIST

Marker genes help determine the effectiveness of targeted molecular drug regimen for treating GIST

Study finds survival rates from GIST improving among African-Americans

Study finds survival rates from GIST improving among African-Americans

Gleevec reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors

Gleevec reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors

Study shows surgery provides good long-term outcomes for patients with gastrointestinal cancers

Study shows surgery provides good long-term outcomes for patients with gastrointestinal cancers

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

More good Gleevec news

More good Gleevec news

Modified form of imatinib becomes more specific

Modified form of imatinib becomes more specific

Gleevec available to patients in post-surgical GIST study

Gleevec available to patients in post-surgical GIST study

Maraviroc to receive accelerated review in U.S. and Europe

Maraviroc to receive accelerated review in U.S. and Europe

Gleevec may cause heart problems

Gleevec may cause heart problems

Gleevec strangles drug-resistant, metastatic prostate cancer

Gleevec strangles drug-resistant, metastatic prostate cancer

Long-term benefits of imatinib for patients newly diagnosed with chronic myelogenous leukemia

Long-term benefits of imatinib for patients newly diagnosed with chronic myelogenous leukemia

Study confirms Gleevec's long-term benefits in treating advanced gastrointestinal stromal tumors

Study confirms Gleevec's long-term benefits in treating advanced gastrointestinal stromal tumors

Cancer treatment interferes with bone development

Cancer treatment interferes with bone development

New way to study proteins in live cells

New way to study proteins in live cells

Researchers at Johns Hopkins have identified three new genetic mutations in brain tumors

Researchers at Johns Hopkins have identified three new genetic mutations in brain tumors

New study demonstrates high rates of tumor death in patients receiving regimen

New study demonstrates high rates of tumor death in patients receiving regimen